A COMMON ERROR IN USING COMBINED TREATMENT WITH RITUXIMAB AND PLASMAPHERESIS (PP) TO PREVENT OR TREAT ANTIBODY MEDIATED REJECTION (AMR)
2020
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI